Medesis Pharma S.A. (EPA:ALMDP)
0.3500
0.00 (0.00%)
Inactive · Last trade price on May 14, 2025
Revance Therapeutics Revenue
Medesis Pharma had revenue of 31.15K EUR in the half year ending June 30, 2024, a decrease of -13.10%. This brings the company's revenue in the last twelve months to 63.64K, down -85.17% year-over-year. In the year 2023, Medesis Pharma had annual revenue of 300.03K with 52.07% growth.
Revenue (ttm)
63.64K
Revenue Growth
-85.17%
P/S Ratio
27.83
Revenue / Employee
6.36K
Employees
10
Market Cap
1.77M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 300.03K | 102.74K | 52.07% |
Dec 31, 2022 | 197.30K | 101.57K | 106.10% |
Dec 31, 2021 | 95.73K | -112.77K | -54.09% |
Dec 31, 2020 | 208.50K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition